We serve 4′-ethynyl-2-fluoro-2′-deoxyadenosine CAS:865363-93-5 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Product Name: 4'-ethynyl-2-fluoro-2'-deoxyadenosine
Synonym: 2'-deoxy-4'-C-ethynyl-2-fluoro-Adenosine; EFdA; MK-8591
Cas No.: 865363-93-5
Formula: C12H12FN5O3
MW: 293.25
EINECS No.:N.A
HS Code: 2938909090
UN No.: N.A
Hazard class: Non-dangerous goods
Specification
Application
Pharmaceutical intermediate.
Packaging
25 kg/barrel, can also be packaged according to customer requirements.
Storage
Store in a cool, ventilated warehouse.
Keep away from fire and heat.
The temperature should not exceed 37 °C.
Contact us for information like 4′-ethynyl-2-fluoro-2′-deoxyadenosine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MK-8591 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,EFdA Use and application,EFdA technical grade,usp/ep/jp grade.
Related News: Cost: Hedge prices of thick product lines + self-produced intermediates fluctuate, and sufficient supply of upstream raw materials can significantly promote the production of APIs.4-[(4-Methyl-1-piperazinyl)methyl]benzoic acid manufacturer The on-body wear is similar to that of an insulin pump. Unlike insulin pump therapy, however, the investigational system is designed such that users enter only their body weight for the iLet to initialize therapy.2-bromo-8-fluoro-4,5-dihydro-1H-azepino[5,4,3-cd]indol-6(3H)-one supplier The on-body wear is similar to that of an insulin pump. Unlike insulin pump therapy, however, the investigational system is designed such that users enter only their body weight for the iLet to initialize therapy.4-Propylphenylboronic acid vendor The pharmaceutical industry is related to the national economy and the people’s livelihood. The entire upstream and downstream areas involve all aspects of the national economy. Our government has a long-term direct or indirect policy preference for this.The pharmaceutical industry is related to the national economy and the people’s livelihood. The entire upstream and downstream areas involve all aspects of the national economy. Our government has a long-term direct or indirect policy preference for this.